Natural killer activity against cultured human neural tumor and fetal brain cells

Cellular Immunology
|February 1, 1985
PubMed

Insights

Neural tumor cells often resist natural killer (NK) cell attacks. This resistance stems from reduced target recognition, impaired NK cell lysis, or both mechanisms, impacting immune evasion strategies.

Area of Science:

  • Immunology
  • Neuro-oncology
  • Cellular Biology

Background:

  • Natural killer (NK) cells are crucial for innate immunity, targeting abnormal cells like tumors.
  • Neural tumors exhibit varied responses to NK cell-mediated killing, suggesting underlying resistance mechanisms.

Purpose of the Study:

  • To investigate the sensitivity of human neural tumor lines and normal brain cells to NK cell-mediated cytolysis.
  • To elucidate the mechanisms contributing to NK cell resistance in neural tumors.

Main Methods:

  • Analysis of NK cell sensitivity in ten human neural tumor lines and three normal human brain cell lines.
  • Assessment of target-binding cell (TBC) frequencies and single-cell lysis assays for bound tumor cell conjugates.

Main Results:

  • Fetal brain cells were sensitive to NK cytolysis, while adult brain cells and eight of ten neural tumor lines showed significant resistance.
  • NK resistance in some tumor lines was attributed to decreased TBC frequencies or reduced lysis of bound targets.
  • One resistant line exhibited defects in both TBC formation and conjugate lysis, while less resistant lines showed higher TBC frequencies or lysis.

Conclusions:

  • Neural tumor resistance to NK cell-mediated killing is multifactorial.
  • Mechanisms include impaired target recognition (reduced TBC) and/or diminished cytotoxic function against bound tumor cells.
  • Understanding these resistance pathways is vital for developing effective immunotherapies for brain tumors.

Related Concept Videos